Anti-p53 (Hu,Ms,Rt) from Mouse – unconj.
-
Overview
SKU BF0604-01 Specificity Species Reactivity Immunogen Host Species Isotype Clonality (Mono-/Polyclonal) Application ELISA, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (frozen sections), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections), Western Blot
Conjugation Dilution ELISA 1:10,000, Immunofluorescence 1:200, Immunohistochemistry (IHC): 1:200 – 1:1,000, Western Blot (WB): 1:500 – 1:2,000
Format 0,02% NaN3, 150 mM NaCl, 1mg/ml Antibody, 50% Glycerol, affinity purified antibody, in PBS w/o Ca2+ & Mg2+ (pH 7,4)
Intended Use Temperature - Storage Temperature - Transport Manufacturer / Brand Uniprot_ID Alias Antigen NY-CO-13, Cellular Tumor Antigen P53, LFS1, Li-Fraumeni Syndrome, P53, P53 Tumor Suppressor, TP53, Transformation related protein 53, TRP53, Tumor Protein, Tumor Protein p53, Tumor Suppressor P53
- Datasheets and Downloads
-
Additional Product Information
Acts as a tumor suppressor in many tumor types, induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis, the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
p53 antibody detects endogenous levels of total p53.
Contact